Top

Published in:

01-11-2020 | Echocardiography

The pivotal role of cardiovascular imaging in the identification and risk stratification of non-compaction cardiomyopathy patients

Authors: Sophie I. Mavrogeni, George Markousis-Mavrogenis, Vasiliki Vartela, Dionysia Manolopoulou, Elena Abate, Ali Hamadanchi, Angelos G. Rigopoulos, Genovefa Kolovou, Michel Noutsias

Published in: Heart Failure Reviews | Issue 6/2020

Abstract

Non-compaction cardiomyopathy (NCM) is a heterogeneous myocardial disease that can finally lead to heart failure, arrhythmias, and/or embolic events. Therefore, early diagnosis and treatment is of paramount importance. Furthermore, genetic assessment and counseling are crucial for individual risk assessment and family planning. Echocardiography is the first-line imaging modality. However, it is hampered by interobserver variability, depends among others on the quality of the acoustic window, cannot assess reliably the right ventricle and the apex, and cannot provide tissue characterization. Cardiovascular magnetic resonance (CMR) provides a 3D approach allowing imaging of the entire heart, including both left and right ventricle, with low operator variability or limitations due to patient’s body structure. Furthermore, tissue characterization, using late gadolinium enhancement (LGE), allows the detection of fibrotic areas possibly representing the substrate for potentially lethal arrhythmias, predicts the severity of LV systolic dysfunction, and differentiates apical thrombus from fibrosis. Conversely, besides being associated with high costs, CMR has long acquisition/processing times, lack of expertise among cardiologists/radiologists, and limited availability. Additionally, in cases of respiratory and/or cardiac motion artifacts or arrhythmias, the cine images may be blurred. However, CMR cannot be applied to patients with not CMR-compatible implanted devices and LGE may be not available in patients with severely reduced GFR. Nevertheless, native T1 mapping can provide detailed tissue characterization in such cases. This tremendous potential of CMR makes this modality the ideal tool for better risk stratification of NCM patient, based not only on functional but also on tissue characterization information.

Chin TK, Perloff JK, Williams RG, Jue K, Mohrmann R (1990) Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation 82:507–513. https://doi.org/10.1161/01.CIR.82.2.507CrossRefPubMed

Grant RT (1926) An unusual anomaly of the coronary vessels in the malformed heart of a child. Heart 13:273–283

Frischknecht BS, Jost CHA, Oechslin EN et al (2005) Validation of noncompaction criteria in dilated cardiomyopathy, and valvular and hypertensive heart disease. J Am Soc Echocardiogr 18:865–872. https://doi.org/10.1016/j.echo.2005.03.011CrossRefPubMed

Towbin JA, Ballweg J, Johnson J (2017) Left ventricular noncompaction cardiomyopathy. In: heart failure in the child and young adult: from bench to bedside. Elsevier, pp 269–290

Oechslin EN, Attenhofer Jost CH, Rojas JR, Kaufmann PA, Jenni R (2000) Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 36:493–500. https://doi.org/10.1016/S0735-1097(00)00755-5CrossRefPubMed

Garcia-Pavia P, De La Pompa JL (2014) Left ventricular noncompaction: a genetic cardiomyopathy looking for diagnostic criteria. J Am Coll Cardiol 64:1981–1983CrossRef

Oechslin E, Jenni R (2011) Left ventricular non-compaction revisited: a distinct phenotype with genetic heterogeneity? Eur Heart J 32:1446–1456CrossRef

Arbustini E, Weidemann F, Hall JL (2014) Left ventricular noncompaction: a distinct cardiomyopathy or a trait shared by different cardiac diseases? J Am Coll Cardiol 64:1840–1850CrossRef

Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB, American Heart Association, Council on Clinical Cardiology, Heart Failure and Transplantation Committee, Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups, Council on Epidemiology and Prevention (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and Functio. Circulation 113:1807–1816. https://doi.org/10.1161/CIRCULATIONAHA.106.174287CrossRefPubMed

10.

Richardson P, McKenna RW, Bristow M et al (1996) Report of the 1995 World Health Organization/international society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:841–842CrossRef

11.

Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna W, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A (2008) Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 29:270–276. https://doi.org/10.1093/eurheartj/ehm342CrossRefPubMed

12.

Westphal JG, Rigopoulos AG, Bakogiannis C, Ludwig SE, Mavrogeni S, Bigalke B, Doenst T, Pauschinger M, Tschöpe C, Schulze PC, Noutsias M (2017) The MOGE(S) classification for cardiomyopathies: current status and future outlook. Heart Fail Rev 22:743–752CrossRef

13.

Paterick TE, Umland MM, Jan MF et al (2012) Left ventricular noncompaction: a 25-year odyssey. J Am Soc Echocardiogr 25:363–375CrossRef

14.

Carrilho-Ferreira P, Almeida AG, Pinto FJ (2014) Non-compaction cardiomyopathy: Prevalence, prognosis,pathoetiology, genetics, and risk of cardioembolism. Curr Heart Fail Rep 11:393–403. https://doi.org/10.1007/s11897-014-0227-3, Non-compaction cardiomyopathy: prevalence, prognosis, pathoetiology, genetics, and risk of cardioembolism

15.

Rigopoulos A, Rizos IK, Aggeli C et al (2002) Isolated left ventricular noncompaction: an unclassified cardiomyopathy with severe prognosis in adults. Cardiology 98:25–32. https://doi.org/10.1159/000064677CrossRefPubMed

16.

Luijkx T, Cramer MJ, Zaidi A, Rienks R, Senden PJ, Sharma S, van Hellemondt F, Buckens CF, Mali WP, Velthuis BK (2012) Ethnic differences in ventricular hypertrabeculation on cardiac MRI in elite football players. Neth Hear J 20:389–395. https://doi.org/10.1007/s12471-012-0305-7CrossRef

17.

Kohli SK, Pantazis AA, Shah JS, Adeyemi B, Jackson G, McKenna W, Sharma S, Elliott PM (2008) Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J 29:89–95. https://doi.org/10.1093/eurheartj/ehm481CrossRefPubMed

18.

Stöllberger C, Winkler-Dworak M, Blazek G, Finsterer J (2004) Left ventricular hypertrabeculation/noncompaction with and without neuromuscular disorders. Int J Cardiol 97:89–92. https://doi.org/10.1016/j.ijcard.2003.08.014CrossRefPubMed

19.

Yaplito-Lee J, Weintraub R, Jamsen K, Chow CW, Thorburn DR, Boneh A (2007) Cardiac manifestations in oxidative phosphorylation disorders of childhood. J Pediatr 150:407–411. https://doi.org/10.1016/j.jpeds.2006.12.047CrossRefPubMed

20.

Uusimaa J, Remes AM, Rantala H et al (2000) Childhood encephalopathies and myopathies: a prospective study in a defined population to assess the frequency of mitochondrial disorders. Pediatrics 105:598–603. https://doi.org/10.1542/peds.105.3.598CrossRefPubMed

21.

Finsterer J, Støllberger C, Schubert B (2004) Acquired left ventricular hypertrabeculation/noncompaction in mitochondriopathy. Cardiology 102:228–230CrossRef

22.

Ichida F, Tsubata S, Bowles KR, Haneda N, Uese K, Miyawaki T, Dreyer WJ, Messina J, Li H, Bowles NE, Towbin JA (2001) Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation 103:1256–1263. https://doi.org/10.1161/01.CIR.103.9.1256CrossRefPubMed

23.

Bleyl SB, Mumford BR, Thompson V, Carey JC, Pysher TJ, Chin TK, Ward K (1997) Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am J Hum Genet 61:868–872. https://doi.org/10.1086/514879CrossRefPubMedPubMedCentral

24.

Battaglia A, Hoyme HE, Dallapiccola B et al (2008) Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation. Pediatrics 121:404–410. https://doi.org/10.1542/peds.2007-0929CrossRefPubMed

25.

Probst S, Oechslin E, Schuler P, Greutmann M, Boyé P, Knirsch W, Berger F, Thierfelder L, Jenni R, Klaassen S (2011) Sarcomere gene mutations in isolated left ventricular noncompaction cardiomyopathy do not predict clinical phenotype. Circ Cardiovasc Genet 4:367–374. https://doi.org/10.1161/CIRCGENETICS.110.959270CrossRefPubMed

26.

Hoedemaekers YM, Caliskan K, Michels M, Frohn-Mulder I, van der Smagt J, Phefferkorn JE, Wessels MW, ten Cate F, Sijbrands EJ, Dooijes D, Majoor-Krakauer DF (2010) The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy. Circ Cardiovasc Genet 3:232–239. https://doi.org/10.1161/CIRCGENETICS.109.903898CrossRefPubMed

27.

Chang B, Nishizawa T, Furutani M, Fujiki A, Tani M, Kawaguchi M, Ibuki K, Hirono K, Taneichi H, Uese K, Onuma Y, Bowles NE, Ichida F, Inoue H, Matsuoka R, Miyawaki T, Noncompaction study collaborators (2011) Identification of a novel TPM1 mutation in a family with left ventricular noncompaction and sudden death. Mol Genet Metab 102:200–206. https://doi.org/10.1016/j.ymgme.2010.09.009CrossRefPubMed

28.

Zuckerman WA, Richmond ME, Singh RK, Carroll SJ, Starc TJ, Addonizio LJ (2011) Left-ventricular noncompaction in a pediatric population: predictors of survival. Pediatr Cardiol 32:406–412. https://doi.org/10.1007/s00246-010-9868-5CrossRefPubMed

29.

Rigopoulos AG, Noutsias M (2019) Prognostic risk stratification in left ventricular noncompaction: still a long way to go. Cardiol. 142:220–222CrossRef

30.

Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA (2001) Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 86:666–671. https://doi.org/10.1136/heart.86.6.666CrossRefPubMedPubMedCentral

31.

Stöllberger C, Gerecke B, Finsterer J, Engberding R (2013) Refinement of echocardiographic criteria for left ventricular noncompaction. Int J Cardiol 165:463–467. https://doi.org/10.1016/j.ijcard.2011.08.845CrossRefPubMed

32.

Tarando F, Coisne D, Galli E, Rousseau C, Viera F, Bosseau C, Habib G, Lederlin M, Schnell F, Donal E (2017) Left ventricular non-compaction and idiopathic dilated cardiomyopathy: the significant diagnostic value of longitudinal strain. Int J Cardiovasc Imaging 33:83–95. https://doi.org/10.1007/s10554-016-0980-3CrossRefPubMed

33.

Gianfagna P, Badano LP, Faganello G, Tosoratti E, Fioretti PM (2006) Additive value of contrast echocardiography for the diagnosis of noncompaction of the left ventricular myocardium. Eur J Echocardiogr 7:67–70. https://doi.org/10.1016/j.euje.2005.03.001CrossRefPubMed

34.

McCrohon J a. (2002) Isolated noncompaction of the myocardium: a rarity or missed diagnosis? Circulation 106:22e–23. https://doi.org/10.1161/01.CIR.0000028961.66881.2D

35.

Pignatelli RH, McMahon CJ, Dreyer WJ et al (2003) Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy. Circulation 108:2672–2678. https://doi.org/10.1161/01.CIR.0000100664.10777.B8CrossRefPubMed

36.

Petersen SE, Selvanayagam JB, Wiesmann F, Robson MD, Francis JM, Anderson RH, Watkins H, Neubauer S (2005) Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 46:101–105. https://doi.org/10.1016/j.jacc.2005.03.045CrossRefPubMed

37.

Ashrith G, Gupta D, Hanmer J, Weiss RM (2014) Cardiovascular magnetic resonance characterization of left ventricular non-compaction provides independent prognostic information in patients with incident heart failure or suspected cardiomyopathy. J Cardiovasc Magn Reson 16:64. https://doi.org/10.1186/s12968-014-0064-2CrossRefPubMedPubMedCentral

38.

Kawel N, Nacif M, Arai AE, Gomes AS, Hundley WG, Johnson WC, Prince MR, Stacey RB, Lima JA, Bluemke DA (2012) Trabeculated (noncompacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging 5:357–366. https://doi.org/10.1161/CIRCIMAGING.111.971713CrossRefPubMedPubMedCentral

39.

Bonamini R, Imazio M, Faletti R, Gatti M, Xhyheri B, Limone M, Longo F, Piga A (2019) Prevalence and prognostic impact of left ventricular non-compaction in patients with thalassemia. Intern Emerg Med 14:1299–1306. https://doi.org/10.1007/s11739-019-02114-3CrossRefPubMed

40.

Piga A, Longo F, Musallam KM, Veltri A, Ferroni F, Chiribiri A, Bonamini R (2012) Left ventricular noncompaction in patients with β-thalassemia: uncovering a previously unrecognized abnormality. Am J Hematol 87:1079–1083. https://doi.org/10.1002/ajh.23323CrossRefPubMed

41.

Chiodi E, Nardozza M, Gamberini MR, Pepe A, Lombardi M, Benea G, Mele D (2017) Left ventricle remodeling in patients with β-thalassemia major. An emerging differential diagnosis with left ventricle noncompaction disease. Clin Imaging 45:58–64. https://doi.org/10.1016/j.clinimag.2017.05.010CrossRefPubMed

42.

Grothoff M, Pachowsky M, Hoffmann J, Posch M, Klaassen S, Lehmkuhl L, Gutberlet M (2012) Value of cardiovascular MR in diagnosing left ventricular non-compaction cardiomyopathy and in discriminating between other cardiomyopathies. Eur Radiol 22:2699–2709. https://doi.org/10.1007/s00330-012-2554-7CrossRefPubMedPubMedCentral

43.

Jacquier A, Thuny F, Jop B, Giorgi R, Cohen F, Gaubert JY, Vidal V, Bartoli JM, Habib G, Moulin G (2010) Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. Eur Heart J 31:1098–1104. https://doi.org/10.1093/eurheartj/ehp595CrossRefPubMed

44.

Positano V, Meloni A, Macaione F, Santarelli MF, Pistoia L, Barison A, Novo S, Pepe A (2018) Non-compact myocardium assessment by cardiac magnetic resonance: dependence on image analysis method. Int J Cardiovasc Imaging 34:1227–1238. https://doi.org/10.1007/s10554-018-1331-3CrossRefPubMed

45.

Fazio G, Lunetta M, Grassedonio E et al (2010) Noncompaction of the right ventricle. Pediatr Cardiol 31:576–578CrossRef

46.

Burke A, Mont E, Kutys R, Virmani R (2005) Left ventricular noncompaction: a pathological study of 14 cases. Hum Pathol 36:403–411. https://doi.org/10.1016/j.humpath.2005.02.004CrossRefPubMed

47.

Vogel-Claussen J, Rochitte CE, Wu KC, Kamel IR, Foo TK, Lima JA, Bluemke DA (2006) Delayed enhancement MR imaging: utility in myocardial assessment. Radiographics 26:795–810CrossRef

48.

Jassal DS, Nomura CH, Neilan TG, Holmvang G, Fatima U, Januzzi J, Brady TJ, Cury RC (2006) Delayed enhancement cardiac MR imaging in noncompaction of left ventricular myocardium. J Cardiovasc Magn Reson 8:489–491. https://doi.org/10.1080/10976640600599502CrossRefPubMed

49.

Nucifora G, Aquaro GD, Pingitore A, Masci PG, Lombardi M (2011) Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severity. Eur J Heart Fail 13:170–176. https://doi.org/10.1093/eurjhf/hfq222CrossRefPubMed

50.

Cummings KW, Bhalla S, Javidan-Nejad C, Bierhals AJ, Gutierrez FR, Woodard PK (2009) A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging. Radiographics 29:89–103. https://doi.org/10.1148/rg.291085052CrossRefPubMed

51.

Dodd JD, Holmvang G, Hoffmann U, Ferencik M, Abbara S, Brady TJ, Cury RC (2007) Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI: correlation with clinical severity. Am J Roentgenol 189:974–980. https://doi.org/10.2214/AJR.07.2364CrossRef

52.

Lachhab A, Doghmi N, Elfakir Y et al (2012) Insights from magnetic resonance imaging of left ventricular non-compaction in adults of north African descent. Int Arch Med 5. https://doi.org/10.1186/1755-7682-5-10

53.

Marín Rodríguez C, Ossaba Vélez S, Maroto Álvaro E, Sánchez Alegre ML (2010) Lack of MR late-enhancement in left ventricular non-compaction in infants and young children. Radiologia 52:138–143. https://doi.org/10.1016/s2173-5107(10)70010-0CrossRefPubMed

54.

Towbin JA, Jefferies JL (2017) Cardiomyopathies due to left ventricular noncompaction, mitochondrial and storage diseases, and inborn errors of metabolism. Circ Res 121:838–854. https://doi.org/10.1161/CIRCRESAHA.117.310987CrossRefPubMed

55.

Araujo-Filho JAB, Assuncao AN, Tavares De Melo MD et al (2018) Myocardial T1 mapping and extracellular volume quantification in patients with left ventricular non-compaction cardiomyopathy. Eur Heart J Cardiovasc Imaging 19:888–895. https://doi.org/10.1093/ehjci/jey022CrossRefPubMed

56.

Zhou H, Lin X, Fang L, Zhao X, Ding H, Chen W, Xu R, Bai X, Wang Y, Fang Q (2016) Characterization of compacted myocardial abnormalities by cardiac magnetic resonance with native T1 mapping in left ventricular non-compaction patients: a comparison with late gadolinium enhancement. Circ J 80:1210–1216. https://doi.org/10.1253/circj.CJ-15-1269CrossRefPubMed

57.

Mavrogeni SI, Sfikakis PP, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Dimitroulas T, Kolovou G, Kitas GD (2017) Cardiac tissue characterization and imaging in autoimmune rheumatic diseases. JACC Cardiovasc Imaging 10:1387–1396CrossRef

58.

Zuccarino F, Vollmer I, Sanchez G et al (2015) Left ventricular noncompaction: imaging findings and diagnostic criteria. Am J Roentgenol 204:W519–W530CrossRef

59.

Scholtz L, Sarkin A, Lockhat Z (2014) Current clinical applications of cardiovascular magnetic resonance imaging. Cardiovasc J Afr 25:185–190. https://doi.org/10.5830/CVJA-2014-021CrossRefPubMedPubMedCentral

60.

Diwadkar S, Nallamshetty L, Rojas C, Athienitis A, Declue C, Cox C, Patel A, Chae SH (2017) Echocardiography fails to detect left ventricular noncompaction in a cohort of patients with noncompaction on cardiac magnetic resonance imaging. Clin Cardiol 40:364–369. https://doi.org/10.1002/clc.22669CrossRefPubMedPubMedCentral

61.

Choudhary S, Bagarhatta R (2015) Isolated right ventricular non-compaction: a rare form of dilated cardiomyopathy. J Indian Coll Cardiol 5:98–102. https://doi.org/10.1016/j.jicc.2014.04.008CrossRef

62.

Ferreira PF, Gatehouse PD, Mohiaddin RH, Firmin DN (2013) Cardiovascular magnetic resonance artefacts. J Cardiovasc Magn Reson 15

Title: The pivotal role of cardiovascular imaging in the identification and risk stratification of non-compaction cardiomyopathy patients
Authors: Sophie I. Mavrogeni
George Markousis-Mavrogenis
Vasiliki Vartela
Dionysia Manolopoulou
Elena Abate
Ali Hamadanchi
Angelos G. Rigopoulos
Genovefa Kolovou
Michel Noutsias
Publication date: 01-11-2020
Publisher: Springer US
Keywords: Echocardiography
Cardiomyopathy
Heart Failure
Echocardiography
Published in: Heart Failure Reviews / Issue 6/2020
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-019-09898-8

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

The pivotal role of cardiovascular imaging in the identification and risk stratification of non-compaction cardiomyopathy patients

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2020

Survival outcomes of stenting outflow graft stenosis in continuous-flow left ventricular assist devices: a systematic review

Cost-effectiveness analysis of PCSK9 inhibitors in cardiovascular diseases: a systematic review

Effect of antidepressants on death in patients with heart failure: a systematic review and meta-analysis

“The heart supporters”: systematic review for ventricle assist devices in congenital heart surgery

Ultrasound guidance for volume management in patients with heart failure

Real-world comparisons of reduced-dose non-vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation: a systematic review and meta-analysis

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page